-1154G > A | Controls | Cases | OR (95% IC)b | DIE Cases | OR (95% IC)c | Stages III-IV | OR (95% IC)d |
---|---|---|---|---|---|---|---|
(n = 106) | (n = 161) | (n = 131) | (n = 97) | ||||
N (%) | N (%) | N (%) | N (%) | ||||
Genotypes | |||||||
GG | 74 (69.8) | 90 (55.9) | 1a | 75 (57.3) | 1a | 56 (57.7) | 1a |
GA | 30 (28.3) | 56 (34.8) | 1.54 (0.90 - 2.63) | 44 (33.6) | 1.45 (0.82 - 2.54) | 29 (29.9) | 1.28 (0.69 - 2.37) |
AA | 2 (1.9) | 15 (9.3) | 6.17 (1.37 - 27.8) | 12 (9.1) | 5.92 (1.28 - 27.4) | 12 (12.4) | 7.93 (1.70 - 36.9) |
Non-GG (GA + AA) | 32 (30.2) | 71 (44.1) | 1.82 (1.09 - 3.06) | 56 (42.7) | 1.73 (1.01 - 2.96) | 41 (42.3) | 1.69 (0.95 - 3.02) |
Allele | |||||||
G | 178 (84.0) | 236 (73.3) | 1a | 194 (74.1) | 1a | 141 (72.7) | 1a |
A | 34 (16.0) | 86 (26.7) | 1.90 (1.23 - 2.97) | 68 (25.9) | 1.83 (1.16 - 2.90) | 53 (27.3) | 1.97 (1.21 - 3.19) |